Project Grant K23DA062104
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study on momentary distress intolerance and its relationship to cigarette smoking among adults with emotional distress. The $233,913 award to Rutgers, The State University will fund a 5-year research plan involving qualitative investigation, ecological momentary assessment, and longitudinal modeling to better understand...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
- This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop machine learning approaches to personalize cigarette smoking risk prediction for adults trying to quit smoking. The $200,676 award supports research to identify dynamic patterns and key features that predict smoking lapses and relapses during quit attempts, in order to inform the development of personalized smoking cessation interventions and clinical...
- This federal Project Grant award, in the amount of $798,473, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research to develop and evaluate a brief, web-based intervention called Regulation of Craving Training (ROC-T) for smoking cessation. The project aims to test two versions of ROC-T - one focused on reappraisal skills and one on mindfulness-based acceptance - as a preparation intervention to be...
- The Cooperative Agreement award titled "ACTIFY! AN MHEALTH MOOD MANAGEMENT TOOL TO IMPROVE POPULATION-LEVEL SMOKING CESSATION" is funded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH). The $893,044 award will fund a randomized controlled trial to evaluate the efficacy of the ACTIFY! mobile health app, which combines behavioral activation therapy with standard smoking cessation support. The goal is to determine if this integrated...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research on the "Addiction Potential, Flavoring Content, and Substitutability of Concept Flavored Cigarillos." The $752,701 award, with a performance period from August 1, 2025 to May 31, 2030, will be conducted by the University of Oklahoma Health Sciences Center (OUHSC). The research aims to investigate the addiction...
- This $105,076 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the neurocomputational basis of effort-based decision making (EBDM) in individuals with tobacco use disorder, tobacco and opioid use disorder, and healthy controls. The award will support research to characterize the neurocomputational basis of EBDM during a smoking cessation attempt. The project will computationally model...
- This Project Grant award, titled "PROJECT DEDUCE: DIGITAL ENVIROTYPING TO DEVELOP UNDERSTANDING OF CIGARETTE SMOKING AND THE ENVIRONMENT", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to leverage computer vision and digital tools to accurately characterize the environments of people who smoke, with the goal of identifying environmental markers of smoking behavior and relapse risk. The...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $431,643 Project Grant to The Research Foundation for the State University of New York (RF SUNY) to develop and test a telehealth-delivered, pain-targeted motivational smoking cessation intervention for smokers with chronic pain who are not ready to quit. The project aims to overcome barriers to in-person treatment by delivering the intervention via telehealth in a Stage 1...
This $139,457 Project Grant award, issued by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs), supports a research project at the University of Oklahoma Health Sciences Center (OUHSC). The project aims to: Evaluate the role of depressive symptoms on smoking cessation and treatment mechanisms using a Just-In-Time Adaptive Intervention (JITAI) approach. This will examine how treatment mechanisms vary between adults with and without elevated depressive symptoms. Investigate how transdiagnostic depressive and smoking abstinence symptoms interfere with treatment, focusing on processes like atypical motivation to positive and aversive contexts. The 5-year project, running from September 2025 to August 2030, will leverage JITAI technology and ecological momentary assessments to better understand and optimize smoking cessation treatment for individuals with comorbid depression.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $139.5k | 8/19/25 |